Plain language summary of the EMPEROR-Preserved study looking at the effect of empagliflozin in patients with heart failure with preserved ejection fraction, with and without diabetes

Future Cardiology, Ahead of Print.
Source: Future Cardiology - Category: Cardiology Authors: Source Type: research